CBPLPharmaceuticals
Chandra Bhagat Pharma Ltd — Cash Flow Statement
₹30.50
-4.77%
Chandra Bhagat Pharma Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -6.91 Cr | 3.89 Cr | 4.90 Cr | 12.30 Cr | — |
| Capital Expenditure | -1.20 Cr | -2.28 Cr | -0.37 Cr | -0.10 Cr | — |
| End Cash Position | 0.67 Cr | 4.96 Cr | 6.44 Cr | 5.68 Cr | — |
| Beginning Cash Position | 4.96 Cr | 6.44 Cr | 5.68 Cr | 2.82 Cr | — |
| Changes In Cash | -4.30 Cr | -1.48 Cr | 0.76 Cr | 2.86 Cr | — |
| Financing Cash Flow | 2.19 Cr | -5.80 Cr | -4.45 Cr | -9.62 Cr | — |
| Net Other Financing Charges | -1000.00 | — | — | 1000.00 | 1000.00 |
| Interest Paid Cff | -1.95 Cr | -1.39 Cr | -2.19 Cr | -3.08 Cr | — |
| Net Issuance Payments Of Debt | 4.14 Cr | -4.41 Cr | -2.26 Cr | -6.55 Cr | — |
| Net Short Term Debt Issuance | 3.56 Cr | -36000.00 | -0.68 Cr | -1.25 Cr | — |
| Net Long Term Debt Issuance | 0.58 Cr | -4.41 Cr | -1.58 Cr | -5.30 Cr | — |
| Investing Cash Flow | -0.78 Cr | -1.85 Cr | -0.06 Cr | 0.09 Cr | — |
| Net Other Investing Changes | -0.05 Cr | 0.42 Cr | 0.30 Cr | 0.09 Cr | — |
| Interest Received Cfi | 0.02 Cr | 67000.00 | 27000.00 | 0.09 Cr | — |
| Net PPE Purchase And Sale | -0.75 Cr | -2.28 Cr | -0.37 Cr | -0.09 Cr | — |
| Sale Of PPE | 0.45 Cr | 0.00 | 29000.00 | 0.01 Cr | — |
| Purchase Of PPE | -1.20 Cr | -2.28 Cr | -0.37 Cr | -0.10 Cr | — |
| Operating Cash Flow | -5.71 Cr | 6.18 Cr | 5.26 Cr | 12.40 Cr | — |
| Taxes Refund Paid | -0.56 Cr | -0.46 Cr | -0.23 Cr | -0.11 Cr | — |
| Change In Working Capital | -9.00 Cr | 2.50 Cr | 2.14 Cr | 8.38 Cr | — |
| Change In Other Current Liabilities | -0.89 Cr | 33.68 Cr | -10.88 Cr | 16.42 Cr | — |
| Change In Other Current Assets | 3.61 Cr | -3.48 Cr | 1.49 Cr | -2.70 Cr | — |
| Change In Payable | -4.28 Cr | 10.13 Cr | 0.43 Cr | -10.18 Cr | — |
| Change In Inventory | 7.98 Cr | 20.40 Cr | 5.08 Cr | 0.98 Cr | — |
| Change In Receivables | -15.42 Cr | -58.23 Cr | 6.02 Cr | 3.86 Cr | — |
| Other Non Cash Items | 1.80 Cr | 1.38 Cr | 2.18 Cr | 2.99 Cr | — |
| Depreciation And Amortization | 0.88 Cr | 0.49 Cr | 0.11 Cr | 0.04 Cr | — |
| Depreciation | 0.88 Cr | 0.49 Cr | 0.11 Cr | 0.04 Cr | — |
| Net Income From Continuing Operations | 1.17 Cr | 2.26 Cr | 1.16 Cr | 1.10 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | -1000.00 | -1000.00 | — |
| Issuance Of Capital Stock | — | — | — | — | 0.00 |
| Net Common Stock Issuance | — | — | — | — | 0.00 |
| Common Stock Issuance | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Chandra Bhagat Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.